-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TUqcorA1YqHnwtzkh/bij/ZnBGd57W03QKaOpz3dZI90E80A9QbDNDQzuBWCM3E1 8VWj6aThy+FxqDvfbS8oQg== 0001399490-08-000036.txt : 20080512 0001399490-08-000036.hdr.sgml : 20080512 20080512153630 ACCESSION NUMBER: 0001399490-08-000036 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080331 FILED AS OF DATE: 20080512 DATE AS OF CHANGE: 20080512 EFFECTIVENESS DATE: 20080512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Redmile Group, LLC CENTRAL INDEX KEY: 0001425738 IRS NUMBER: 208592298 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-12776 FILM NUMBER: 08823119 BUSINESS ADDRESS: STREET 1: ONE FERRY BUILDING, SUITE 255 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-677-5341 MAIL ADDRESS: STREET 1: ONE FERRY BUILDING, SUITE 255 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 red1q08.txt REDMILE GROUP, LLC 13F-HR 1Q08 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: March 31, 2008 Check here if Amendment [ ]; Amendment Number: This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Redmile Group, LLC Address: One Ferry Building, Suite 255 San Francisco, CA 94111 13F File Number: 28- The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Jeremy Green Title: Managing Member Phone: 415 677 5341 Signature, Place, and Date of Signing: Jeremy Green San Francisco, CA/USA May 12, 2008 Report Type (Check only one.): [ X] 13F HOLDINGS REPORT. [ ] 13F NOTICE. [ ] 13F COMBINATION REPORT. FORM 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 0 Form13F Information Table Entry Total: 28 Form13F Information Table Value Total: $144,613 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional managers with respect to which this report is filed, other than the manager filing this report. NONE FORM 13F INFORMATION TABLE VALUE SHARES/ SH/ PUT/ INVSTMT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DSCRETN MANAGERS SOLE SHARED NONE - ------------------------------ ---------------- --------- -------- -------- --- ---- ------- ------------ -------- -------- -------- ALLOS THERAPEUTICS INC COM 019777101 6831 1123585 SH DEFINED 1123585 ALTUS PHARMACEUTICALS INC COM 02216N105 2357 518040 SH DEFINED 518040 AMGEN INC COM 031162100 6267 150000 SH PUT DEFINED 150000 AUXILIUM PHARMACEUTICALS INC COM 05334D107 4679 175000 SH DEFINED 175000 BIODEL INC COM 09064M105 3492 321800 SH DEFINED 321800 BIOMARIN PHARMACEUTICAL INC COM 09061G101 6993 197700 SH DEFINED 197700 CEPHALON INC COM 156708109 2962 46000 SH CALL DEFINED 46000 ENZO BIOCHEM INC COM 294100102 4584 504342 SH DEFINED 504342 ILLUMINA INC COM 452327109 13305 175300 SH DEFINED 175300 ILLUMINA INC COM 452327109 7043 92800 SH CALL DEFINED 92800 IMCLONE SYS INC COM 45245W109 6893 162500 SH DEFINED 162500 INCYTE CORP COM 45337C102 3468 330000 SH DEFINED 330000 LEMAITRE VASCULAR INC COM 525558201 2084 641159 SH DEFINED 641159 MEDAREX INC COM 583916101 3931 444200 SH DEFINED 444200 MILLENNIUM PHARMACEUTICALS I COM 599902103 1855 120000 SH CALL DEFINED 120000 MILLENNIUM PHARMACEUTICALS I COM 599902103 3259 210829 SH DEFINED 210829 NEKTAR THERAPEUTICS COM 640268108 3140 452521 SH DEFINED 452521 NMT MED INC COM 629294109 1238 318170 SH DEFINED 318170 NXSTAGE MEDICAL INC COM 67072V103 3608 835109 SH DEFINED 835109 PHARMATHENE INC COM 71714G102 152 49100 SH DEFINED 49100 RESMED INC COM 761152107 2446 58000 SH DEFINED 58000 SAVIENT PHARMACEUTICALS INC COM 80517Q100 6785 339272 SH DEFINED 339272 SCHERING PLOUGH CORP COM 806605101 5051 350500 SH DEFINED 350500 THORATEC CORP COM NEW 885175307 7185 502795 SH DEFINED 502795 TOMOTHERAPY INC COM 890088107 4629 322605 SH DEFINED 322605 WRIGHT MED GROUP INC COM 98235T107 12507 518109 SH DEFINED 518109 XENOPORT INC COM 98411C100 5616 138762 SH DEFINED 138762 ZIMMER HLDGS INC COM 98956P102 12253 157370 SH DEFINED 157370
-----END PRIVACY-ENHANCED MESSAGE-----